Initial presentation of unscreened children with sickle cell disease: The Toronto experience

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 397-400

  Lieberman, Lani ^a   Kirby, Melanie ^b   Ozolins, Laura ^c   Mosko, Jeffrey ^d   Friedman, Jeremy ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Newborn screening; Sickle cell anemia; Sickle cell disease

Indexed keywords

PENICILLIN DERIVATIVE;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; AMNIOCENTESIS; APLASTIC ANEMIA; ARTICLE; ASTHMA; BLOOD VESSEL OCCLUSION; CANADA; CHILD; DEATH; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; FEVER; FINGER JOINT; FRACTURE; GASTROENTERITIS; GENOTYPE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; MORBIDITY; MORTALITY; NEWBORN; NEWBORN SCREENING; PATIENT EDUCATION; PRIAPISM; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SCREENING; SEPSIS; SEPTICEMIA; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SPLEEN DISEASE; STROKE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES;

EID: 67651214261     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22023     Document Type: Article

References (26)

1. Serjeant GR, Serjeant BE. Sickle cell disease, 3rd edition. New York, NY: Oxford University Press; 2001.
2. Goldbloom RB. Screening for hemoglobinopathies in Canada. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada; 1994. pp. 206-218.
3. Rogers DW, Clarke JM, Cupidore L, et al. Early deaths in Jamaican children with sickle cell disease. Br Med J 1978;1:1515-1516. (Pubitemid 8376835)
4. Scott RB. Health care priority and sickle cell anemia. JAMA 1970;214:731-734.
5. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-4027. (Pubitemid 38685339)
6. Vichinsky E, Hurst D, Earles A, et al. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 1988;81:749-755. (Pubitemid 18153033)
7. Vichinsky EP. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality. Semin Hematol 1991:28:220-226.
8. Amman A, Addiego J, Wara D, et al. Polyvalent pneumococcal polysaccharide immunization of patients with sickle cell anemia and patients with splenectomy. New Engl J Med 1977;297:897-900. (Pubitemid 8211943)
9. American Academy of Pediatrics: Section on Hematology/Oncology, Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics 2002;109:526-535.
10. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. New Engl J Med 1986;314:1593-1599. (Pubitemid 16118215)
11. Emond AM, Collis R, Darvill D, et al. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 1985;107:201-206. (Pubitemid 15241908)
12. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008;121:562-569.
13. Nichols FT, Jones AM, Adams RJ. Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. J Neuroimaging 2001;11:354-362. (Pubitemid 32917447)
14. Consensus Development Panel, National Institutes of Health. Newborn screening for sickle cell disease and other hemoglobinopathies. J Am Med Assoc 1987;258:1205-1209.
15. National Newborn Screening and Genetics Resource Center. Available at: http://genes-r-us.uthscsa.edu/. Accessed October 23, 2008.
16. Streetly A, Kick M. Screening for haemoglobinopathies. Current Pediatrics 2005;15:32-39.
17. WHO Working Group. Hereditary anemias: Genetic basis, clinical features, diagnosis and treatment. Bull World Health Org 1982;60:643-660.
18. Community control of hereditary anaemias: Memorandum from a WHO meeting. Bull World Health Org 1983;61:63-80.
19. The Council of Regional Networks for Genetics Services (CORN). National Newborn Screening Report-1992. New York, NY: The Council of Regional Networks for Genetic Services; 1995.
20. Bainbridge R, Higgs D, Maude G, et al. Clinical presentation of homozygous sickle cell disease. J Pediatr 1985;106:881-885. (Pubitemid 15006629)
21. British Society for Hematology. Guidelines for haemaglobinopathy screening. Clin Lab Haemat 1988;10:87-94.
22. Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: Follow-up of children, diagnosis, management and evaluation. Statement of the Council of Regional Networks for Genetics Services (CORN). J Pediatr 2000;137: S1-S46.
23. Leiken SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with Sickle cell disease. Pediatrics 1989;84:500-508. (Pubitemid 19216350)
24. Standing Medical Advisory Committee. Sickle cell, thalassaemia and other haemoglobinopathies. London: HMSO; 1993.
25. Panepinto JA, Magid D, Rewers MJ, et al. Universal versus targeted screening of infants for sickle cell disease: A cost effectiveness analysis. J Pediatrics 2000;136:201-208. (Pubitemid 30470991)
26. Tsevat J, Wong JB, Pauker SG, et al. Neonatal screening for sickle cell disease: A cost effectiveness analysis. J Pediatr 1991;118:546-554.